SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

NCT03778996 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma, Ewing
Sarcoma

Interventions

DRUG: Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)

Sponsor

Sarcoma Oncology Research Center, LLC

Collaborators

[object Object]